Trial Profile
A Study to Investigate the Psychomotor and Cognitive Effects of Alcohol When Co-administered With GSK1144814 or Matching Placebo in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Elinzanetant (Primary)
- Indications Alcoholism
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 31 Aug 2010 New trial record